Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M622Revenue $M4.5Net Margin (%)-2,884.1Altman Z-Score7.3
Enterprise Value $M490EPS $-1.4Operating Margin %-2,876.1Piotroski F-Score2
P/E(ttm)--Beneish M-Score16.9Pre-tax Margin (%)-2,867.6Higher ROA y-yN
Price/Book4.310-y EBITDA Growth Rate %--Quick Ratio5.0Cash flow > EarningsY
Price/Sales1275-y EBITDA Growth Rate %--Current Ratio6.3Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-86.1Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-106.3Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M104ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with KERX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
Current Price Change from Average Comment Current Shares
KERXSeth Klarman 2015-06-30 Add0.57%$9.32 - $12.73
$ 5.85-46%Add 15.24%25,791,678
KERXSeth Klarman 2015-03-31 Add0.88%$10.87 - $14.68
$ 5.85-55%Add 22.30%22,380,200
KERXSeth Klarman 2014-09-30 Add1.87%$12.71 - $18.19
$ 5.85-62%Add 73.62%18,300,000
KERXSeth Klarman 2014-06-30 Add1.04%$12.11 - $17.03
$ 5.85-59%Add 67.01%10,539,986
KERXSeth Klarman 2014-03-31 Buy 2.6%$12.16 - $16.88
$ 5.85-61%New holding6,310,850
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

KERX is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!

KERX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Holmes Scott ACFO 2015-08-21Buy5,000$5.722.27view
Madison GregPresident and CEO 2015-08-20Buy9,984$5.692.81view
Neylan John F.Chief Medical Officer 2015-08-12Buy10,000$6.2-5.65view
Madison GregPresident and CEO 2015-08-10Sell1,683$6.07-3.62view
Holmes Scott ACFO 2015-07-31Sell2,758$7.87-25.67view
Adams BrianVP and General Counsel 2015-07-15Sell1,086$9.99-41.44view
Oliviero James F IIICFO 2015-07-06Sell1,943$9.61-39.13view
Tarnok Michael P.Director 2015-05-06Buy10,000$9.73-39.88view
Adams BrianVP and General Counsel 2015-04-15Sell4,320$12.4-52.82view
Oliviero James F IIICFO 2015-04-06Sell1,878$11.68-49.91view

Quarterly/Annual Reports about KERX:

    News about KERX:

    Articles On GuruFocus.com
    main Jul 01 2015 
    main Jul 01 2015 
    Is Seth Klarman right about Keryx Inc.? Jun 25 2015 
    Seth Klarman Buys Pioneer Natural Resources, SunEdison Semiconductor Ltd, Atara Biotherapeutics Inc, May 15 2015 
    my portfolio May 08 2015 
    Analysts Positive on Keryx Biopharmaceuticals, Inc. Despite Weak Prescription Data May 05 2015 
    Roth Capital Weighs In On 5 Biotech Stocks to Watch Apr 05 2015 
    Portfolio Feb 16 2015 
    2015 Must-Buys In Biotech Sector Feb 02 2015 
    me Jan 23 2015 

    More From Other Websites
    5 Breakout Stocks to Trade for Big Gains Aug 28 2015
    Mid-Day Market Update: Tuesday's Top Shorted Stocks Aug 18 2015
    Coverage initiated on Keryx Biopharma by Morgan Stanley Aug 13 2015
    No Longer A Buy: Roth Capital Downgrades Keryx Biopharma, Slashes Price Target To $6 Aug 10 2015
    10-Q for Keryx Biopharmaceuticals, Inc. Aug 08 2015
    Biotech Stock Mailbag: Controversial Stocks Revisited Aug 07 2015
    KERYX BIOPHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report Aug 06 2015
    Keryx Posts In-Line Loss in Q2, Auryxia in Focus - Analyst Blog Aug 06 2015
    [$$] Keryx Shares Could Triple Despite Slower Sales Aug 06 2015
    Edited Transcript of KERX earnings conference call or presentation 5-Aug-15 12:00pm GMT Aug 05 2015
    ​Keryx revenue falls short despite support of analysts, Baupost Aug 05 2015
    KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition,... Aug 05 2015
    Keryx's (KERX) Q2 Loss in-Line with Estimates - Tale of the Tape Aug 05 2015
    Keryx Biopharmaceuticals Inc Earnings Call scheduled for 8:00 am ET today Aug 05 2015
    Keryx Biopharma reports 2Q loss Aug 05 2015
    Keryx Biopharma reports 2Q loss Aug 05 2015
    Q2 2015 Keryx Biopharmaceuticals Inc Earnings Release - Before Market Open Aug 05 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)